Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 23678003)

1.

Adenosine production by human B cells and B cell-mediated suppression of activated T cells.

Saze Z, Schuler PJ, Hong CS, Cheng D, Jackson EK, Whiteside TL.

Blood. 2013 Jul 4;122(1):9-18. doi: 10.1182/blood-2013-02-482406. Epub 2013 May 15.

2.

Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.

Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D, Harasymczuk M, Mandapathil M, Lang S, Jackson EK, Whiteside TL.

Clin Exp Immunol. 2014 Aug;177(2):531-43. doi: 10.1111/cei.12354.

PMID:
24749746
3.

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.

Häusler SF, Montalbán del Barrio I, Strohschein J, Anoop Chandran P, Engel JB, Hönig A, Ossadnik M, Horn E, Fischer B, Krockenberger M, Heuer S, Seida AA, Junker M, Kneitz H, Kloor D, Klotz KN, Dietl J, Wischhusen J.

Cancer Immunol Immunother. 2011 Oct;60(10):1405-18. doi: 10.1007/s00262-011-1040-4. Epub 2011 Jun 3.

PMID:
21638125
4.

Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.

Romio M, Reinbeck B, Bongardt S, Hüls S, Burghoff S, Schrader J.

Am J Physiol Cell Physiol. 2011 Aug;301(2):C530-9. doi: 10.1152/ajpcell.00385.2010. Epub 2011 May 18.

5.

CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.

Serra S, Horenstein AL, Vaisitti T, Brusa D, Rossi D, Laurenti L, D'Arena G, Coscia M, Tripodo C, Inghirami G, Robson SC, Gaidano G, Malavasi F, Deaglio S.

Blood. 2011 Dec 1;118(23):6141-52. doi: 10.1182/blood-2011-08-374728. Epub 2011 Oct 13.

6.

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.

Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Jackson EK, Johnson JT, Gorelik E, Lang S, Whiteside TL.

J Biol Chem. 2010 Sep 3;285(36):27571-80. doi: 10.1074/jbc.M110.127100. Epub 2010 Jun 17.

7.

CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice.

Alam MS, Kurtz CC, Rowlett RM, Reuter BK, Wiznerowicz E, Das S, Linden J, Crowe SE, Ernst PB.

J Infect Dis. 2009 Feb 15;199(4):494-504. doi: 10.1086/596205.

8.

Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.

Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z.

J Immunol. 2011 Jul 15;187(2):676-83. doi: 10.4049/jimmunol.1003884. Epub 2011 Jun 15.

9.

A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Kaku H, Cheng KF, Al-Abed Y, Rothstein TL.

J Immunol. 2014 Dec 15;193(12):5904-13. doi: 10.4049/jimmunol.1400336. Epub 2014 Nov 12.

PMID:
25392527
10.

CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.

Schuler PJ, Macatangay BJ, Saze Z, Jackson EK, Riddler SA, Buchanan WG, Hilldorfer BB, Mellors JW, Whiteside TL, Rinaldo CR.

AIDS. 2013 Jun 19;27(10):1545-55. doi: 10.1097/QAD.0b013e328360c7f3.

11.

Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.

Bönner F, Borg N, Burghoff S, Schrader J.

PLoS One. 2012;7(4):e34730. doi: 10.1371/journal.pone.0034730. Epub 2012 Apr 13.

12.

Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.

Hilchey SP, Kobie JJ, Cochran MR, Secor-Socha S, Wang JC, Hyrien O, Burack WR, Mosmann TR, Quataert SA, Bernstein SH.

J Immunol. 2009 Nov 15;183(10):6157-66. doi: 10.4049/jimmunol.0900475. Epub 2009 Oct 28.

13.

Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-β.

Regateiro FS, Howie D, Nolan KF, Agorogiannis EI, Greaves DR, Cobbold SP, Waldmann H.

Eur J Immunol. 2011 Oct;41(10):2955-65. doi: 10.1002/eji.201141512. Epub 2011 Sep 6.

PMID:
21770045
14.

Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.

Xu S, Shao QQ, Sun JT, Yang N, Xie Q, Wang DH, Huang QB, Huang B, Wang XY, Li XG, Qu X.

Neuro Oncol. 2013 Sep;15(9):1160-72. doi: 10.1093/neuonc/not067. Epub 2013 Jun 4.

15.

Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation.

Wu J, Li G, Luna C, Spasojevic I, Epstein DL, Gonzalez P.

Invest Ophthalmol Vis Sci. 2012 Oct 1;53(11):7142-8. doi: 10.1167/iovs.12-9968.

16.

Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.

Jenabian MA, Seddiki N, Yatim A, Carriere M, Hulin A, Younas M, Ghadimi E, Kök A, Routy JP, Tremblay A, Sévigny J, Lelievre JD, Levy Y.

PLoS Pathog. 2013;9(4):e1003319. doi: 10.1371/journal.ppat.1003319. Epub 2013 Apr 25.

17.

Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.

Fausther M, Lecka J, Soliman E, Kauffenstein G, Pelletier J, Sheung N, Dranoff JA, Sévigny J.

Am J Physiol Gastrointest Liver Physiol. 2012 Feb 15;302(4):G447-59. doi: 10.1152/ajpgi.00165.2011.. Epub 2011 Dec 1.

18.

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.

Mandapathil M, Szczepanski MJ, Szajnik M, Ren J, Lenzner DE, Jackson EK, Gorelik E, Lang S, Johnson JT, Whiteside TL.

Clin Cancer Res. 2009 Oct 15;15(20):6348-57. doi: 10.1158/1078-0432.CCR-09-1143. Epub 2009 Oct 13.

19.

CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.

Pulte D, Furman RR, Broekman MJ, Drosopoulos JH, Ballard HS, Olson KE, Kizer JR, Marcus AJ.

Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):367-72. doi: 10.1016/j.clml.2011.06.005.

20.

Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.

Silva-Pinto AC, Dias-Carlos C, Saldanha-Araujo F, Ferreira FI, Palma PV, Araujo AG, Queiroz RH, Elion J, Covas DT, Zago MA, Panepucci RA.

Ann Hematol. 2014 Sep;93(9):1457-65. doi: 10.1007/s00277-014-2066-4. Epub 2014 Apr 3.

PMID:
24696091
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk